David Claiborne Cocke, Chief Financial Officer at Tissue Regenix, holds 154.49K shares in Tissue Regenix (Ticker: GB:TRX). Most recently, David Claiborne Cocke Sold 63,207p shares of Tissue Regenix on Jun 19, 2024 for an estimated value of 38.56K.
What is the percentage of profitable transactions made by David Claiborne Cocke?
The percentage of profitable transactions made by David Claiborne Cocke is 60%.
What is the average return per transaction made by David Claiborne Cocke?
The average return per transaction made by David Claiborne Cocke is -1.50%.
What stocks does David Claiborne Cocke hold?
David Claiborne Cocke holds: GB:TRX stocks.
What was David Claiborne Cocke’s latest transaction?
David Claiborne Cocke latest transaction was an Informative Sell of 38.56K.
What was David Claiborne Cocke's most profitable transaction?
David Claiborne Cocke’s most profitable transaction was an Informative Buy of GB:TRX stock on April 6, 2022. The return on the trade was 27.20%.
What is David Claiborne Cocke's role in Tissue Regenix?
David Claiborne Cocke's role in Tissue Regenix is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.